New Nordic Healthbrands AB Six month report January - July 2019

SIX MONTHS 2019

• Net sales amounted to MSEK 220.2 (183.4), an increase of 20.1 percent. In local currencies, the increase was 14.2 percent.
• Gross margin decreased to 70.3 percent (70.5).
• EBITDA increased to MSEK 15.3 (11.1).
• Operating profit increased to MSEK 15.0 (10.8).
• Profit after tax for the period increased to MSEK 12.0 (8.5).
• Earnings per share after tax increased to SEK 1.94 (1.38).

Q2 2019

• Net sales amounted to MSEK 116.5 (95.0), an increase of 22.7 percent. In local currencies, the increase was 18.5 percent.
• Gross margin decreased to 71.0 percent (72.3).
• EBITDA ioncreased to MSEK 6.8 (3.8).
• Operating profit increased to MSEK 6.5 (3.6).
• Profit after tax for the period decreased to MSEK 5.3 (2.9).
• Earnings per share decreased to SEK 0.85 (0.47).

New Nordic Healthbrands AB (publ) Three Month Report January - March 2019

THREE MONTHS 2019

• Net sales amounted to MSEK 103.7 (88.4), an increase of 17.3 per cent. In local currencies, the increase was 9.3 per cent.
• Gross margin increased to 69.5 per cent (68.5).
• EBITDA increased to MSEK 8.5 (7.3).
• Operating profit increased to MSEK 8.4 (7.1).
• Profit after tax for the period increased to MSEK 6.7 (5.6).
• Earnings per share after tax increased to SEK 1.09 (0.91).

New Nordic Healthbrands AB (publ) Årsredovisning 2018

Årsredovisning 2018 New Nordics årsredovisning är nu tillgänglig på bolagets hemsida https://newnordic.se/se/investor/financial-reports.html 

New Nordic Healthbrands AB (publ) Full Year Report January - December 2018

TWELVE MONTHS 2018

• Net sales amounted to MSEK 393.7 (344.7), an increase of 14.2 per cent. In local currencies, the increase was 9.8 per cent.
• Gross margin increased to 70.5 percent (67.4).
• EBITDA increased to MSEK 34.9 (28.5).
• Operating profit increased to MSEK 34.2 (27.7).
• Profit after tax for the period increased to MSEK 26.5 (20.3).
• Earnings per share after tax increased to SEK 4.28 (3.28).

Q4 2018

• Net sales amounted to MSEK 97.6 (86.6), an increase of 12.7 percent. In local currencies, the increase was 9.0 percent.
• Gross margin increased to 71.7 percent (68.2).
• EBITDA increased to MSEK 10.0 (9.9).
• Operating profit increased to MSEK 9.8 (9.6).
• Profit after tax for the period increased to MSEK 7.2 (6.6).
• Earnings per share increased to SEK 1.61 (1.07).

New Nordic Healthbrands AB (publ) Divestment of registered trademark Dermyn® in Sweden

New Nordic Healthbrands AB Nine month report January - September 2018

NINE MONTHS 2018

• Net sales amounted to MSEK 296.1 (258.1), an increase of 14.7 per cent. In local currencies, the increase was 10.0 per cent.
• Gross margin increased to 70.1 percent (69.5).
• EBITDA increased to MSEK 24.9 (18.6).
• Operating profit increased to MSEK 24.4 (18.0).
• Profit after tax for the period increased to MSEK 19.3 (13.7).
• Earnings per share after tax increased to SEK 3.11 (2.20).

Q3 2018

• Net sales amounted to MSEK 112.7 (88.3), an increase of 27.6 percent. In local currencies, the increase was 19.7 percent.
• Gross margin increased to 69.5 percent (66.8).
• EBITDA increased to MSEK 13.8 (9.2).
• Operating profit increased to MSEK 13.6 (9.0).
• Profit after tax for the period increased to MSEK 10.7 (7.0).
• Earnings per share increased to SEK 1.73 (1.13).

New Nordic Healthbrands AB Six month report January - July 2018

SIX MONTHS 2018

• Net sales amounted to MSEK 183.4 (169.8), an increase of 8.0 percent. In local currencies, the increase was 4.9 percent.
• Gross margin increased to 70.5 percent (67.3).
• EBITDA increased to MSEK 11.1 (9.4).
• Operating profit increased to MSEK 10.8 (9.0).
• Profit after tax for the period increased to MSEK 8.5 (6.7).
• Earnings per share after tax increased to SEK 1.38 (1.08).

Q2 2018

• Net sales amounted to MSEK 95.0 (88.9), an increase of 6.9 percent. In local currencies, the increase was 1.7 percent.
• Gross margin increased to 72.3 percent (67.1).
• EBITDA decreased to MSEK 3.8 (5.3).
• Operating profit decreased to MSEK 3.6 (5.1).
• Profit after tax for the period decreased to MSEK 2.9 (3.8).
• Earnings per share decreased to SEK 0.47 (0.61).

På ordinarie bolagsstämma i New Nordic Healthbrands den 26 april 2018 beslutades följande

At the Annual General Meeting of New Nordic Healthbrands AB (publ) on April 26, 2018, the following was resolved

New Nordic Healthbrands AB (publ) Three-month report January - March 2018

Q1 2018

• Net sales amounted to MSEK 88.4 (80.9), an increase of 9.3 percent. In local currencies, the increase was 8.3 percent.
• Gross margin increased to 68.5 percent (67.4).
• EBITDA increased to MSEK 7.3 (4.2).
• Operating profit increased to MSEK 7.1 (4.0).
• Profit after tax for the period increased to MSEK 5.6 (2.9).
• Earnings per share after tax increased to SEK 0.91 (0.47).

New Nordic Healthbrands AB (publ) Annual report 2017